NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor

View buyer

Estimated value

goods

Awarded value

Suppliers

1

Lots

1

1 awarded

Published

27 Jan 2021

Other contracts from The NHS Commissioning Board (operating under the name of NHS England)· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
PMO support for the Cancer Healthcare and AI in Health and Care Programmescall off£1.4m28 Apr 2023
NHS England & Improvement South West - Provision of Health Care Services to Vinney Green Secure Children’s Homecontract£5.2m13 May 2022
Implementation of GP referral pathway to NHS CPCScontract12 May 2022
NHS England and NHS Improvement - Independent Clinical Reviews into Deaths in Custody – South East Health & Justice, Detained Estatescontract29 Apr 2022
Provision of Benchmarking Performance Against the Learning Disability Improvement Standards for NHS Trustscontract£800k18 Mar 2022
NHS National Pharmaceuticals Transition 2022_1contract£468.0m17 Mar 2022
National Patient Safety Improvement Programmes Measurement Supportcontract£750k16 Mar 2022
NHS South of England Branded Medicines - Tranche B and Annualcontract£875.7m08 Mar 2022
Invitation to offer for NHS London Branded Medicines - Tranche A and Annualcontract£276.5m08 Mar 2022
NHS Framework Agreement for the supply of Medical Retinal Vascular Treatmentscontract£450.0m07 Mar 2022

Other contracts awarded to Shire Pharmaceuticals Ltd· 9

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
Human Normal Immunoglobulin and Anti-D Immunoglobulincontract£64.3m23 Jul 2021
Medicinal Products and Pharma Funded Homecare Servicescontract23 Jul 2021
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulincontract22 Jul 2021
Recombinant Von Willebrand Factorcontract£250k22 Feb 2021
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia Acall off£37.2m03 Jul 2020
NHS National Framework Agreement for the Supply of Lanadelumabcall off£4.8m07 Jan 2020
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia Bcontract£38.4m25 Mar 2019
NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedemacall off£24.0m16 Jul 2018
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Irelandcall off£1.6m25 Jun 2018